User profiles for David Cooper

David N. Cooper

Professor of Human Molecular Genetics, Cardiff University, UK
Verified email at cardiff.ac.uk
Cited by 108640

[HTML][HTML] Analysis of protein-coding genetic variation in 60,706 humans

…, J Zou, E Pierce-Hoffman, J Berghout, DN Cooper… - Nature, 2016 - nature.com
Large-scale reference data sets of human genetic variation are critical for the medical and
functional interpretation of DNA sequence changes. Here we describe the aggregation and …

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association …

DS Cooper, GM Doherty, BR Haugen, RT Kloos… - Thyroid, 2009 - liebertpub.com
Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the publication of the American Thyroid …

[HTML][HTML] COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

…, IL Scully, M Cutler, W Kalina, CA Kyratsous, D Cooper… - Nature, 2020 - nature.com
An effective vaccine is needed to halt the spread of the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) pandemic. Recently, we reported safety, tolerability and …

Active shape models-their training and application

TF Cootes, CJ Taylor, DH Cooper, J Graham - Computer vision and image …, 1995 - Elsevier
Model-based vision is firmly established as a robust approach to recognizing and locating
known rigid objects in the presence of noise, clutter, and occlusion. It is more problematic to …

[HTML][HTML] Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants

…, K Schneider, EV Kalinina, D Cooper… - … England Journal of …, 2023 - Mass Medical Soc
Background Whether vaccination during pregnancy could reduce the burden of respiratory
syncytial virus (RSV)–associated lower respiratory tract illness in newborns and infants is …

MutationTaster2: mutation prediction for the deep-sequencing age

JM Schwarz, DN Cooper, M Schuelke, D Seelow - Nature methods, 2014 - nature.com
We compared the predictions of the web versions of MutationTaster2, SIFT (http://sift. jcvi. org/),
PolyPhen-2 (http://genetics. bwh. harvard. edu/pph2/) and PROVEAN (http://provean. jcvi. …

[HTML][HTML] Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine

…, K Koury, P Li, WV Kalina, D Cooper… - New England journal …, 2020 - Mass Medical Soc
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and
the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in …

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

…, S Burton, M Law, J Freund, DJ Chisholm, DA Cooper - Aids, 1998 - journals.lww.com
Objective: To describe a syndrome of peripheral lipodystrophy (fat wasting of the face, limbs
and upper trunk), hyperlipidaemia and insulin resistance in patients receiving potent HIV …

[HTML][HTML] Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months

…, S Bouguermouh, WV Kalina, D Cooper… - … England Journal of …, 2021 - Mass Medical Soc
Background BNT162b2 is a lipid nanoparticle–formulated, nucleoside-modified RNA vaccine
encoding a prefusion-stabilized, membrane-anchored severe acute respiratory syndrome …

[HTML][HTML] BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

…, C Fontes-Garfias, JL Perez, M Cutler, D Cooper… - Nature, 2021 - nature.com
BNT162b2, a nucleoside-modified mRNA formulated in lipid nanoparticles that encodes the
SARS-CoV-2 spike glycoprotein (S) stabilized in its prefusion conformation, has …